Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis

Cancer Research

Volumn 60, Issue 10, 2000, Pages 2579-2583

  Shi, Qian ^a   Xiong, Qinghua ^a   Wang, Bailiang ^a   Le, Xiangdong ^a   Khan, Nasim A ^a   Xie, Keping ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CONTROL; CARCINOGENESIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG METASTASIS; MACROPHAGE ACTIVATION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE TUMOR; TUMOR GROWTH;

ANIMALS; CELL DIVISION; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MELANOMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM METASTASIS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OVARIAN NEOPLASMS; SARCOMA, EXPERIMENTAL; TUMOR CELLS, CULTURED;

EID: 0034657272     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J., 6: 3051-3064, 1992.
2. Tamil, S., and Tannenbaum, S. R. The role of nitric oxide (NO) in the carcinogenic process. Biochim. Biophys. Acta, 1288: F31-F36, 1996.
3. Ambs, S., Hussain, S. P., and Harris, C. C. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J., 11: 443-448, 1997.
4. Fukumura, D., and Jain, R. K. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev., 17: 77-89, 1998.
5. Ambs, S., Merriam, W. G., Ogunfusika, M. O., Bennett, W. P., Ishibe, N., Hussain, S. P., Tzeng, E. E., Geller, D. A., Billiar, T. R., and Harris, C. C. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat. Med., 4: 1371-1376, 1998.
6. Xie, K., and Fidler, I. J. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev., 17: 55-75, 1998.
7. Radomski, M. K., Jenkins, D. C., Holmes, L., and Moncada, S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res., 51: 6073-6078, 1991.
8. Dong, Z., Staroselsky, A. H., Qi, X., Xie, K., and Fidler, I. J. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res., 54: 789-793, 1994.
9. Thomsen, L. L., Miles, D. W., Happerfield, L., Bobrow, L. G., Knowles, R. G., and Moncada, S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 72: 41-44, 1995.
10. Cobbs, C. S., Brenman, J. E., Aldape, K. D., Bredt, D. S., and Israel, M. A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res., 55: 727-730, 1995.
11. Shi, Q., Huang, S., Jiang, W., Kutach, L. S., Ananthaswamy, H. N., and Xie, K. Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53. Cancer Res., 59: 2072-2075, 1999.
12. Jenkins, D. C., Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emson, P. C., and Moncada, S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA, 92: 4392-4396, 1995.
13. Ambs, S., Merriam, W. G., Bennett, W. P., Felley-Bosco, E., Ogunfusika, M. O., Oser, S. M., Klein, S., Shields, P. G., Billiar, T. R., and Harris, C. C. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res., 58: 334-341, 1998.
14. Hibbs, B., Jr., Taintor, R. R., and Vavrin, Z. Macrophage cytotoxicity: role for L-arginine deiminase activity and amino nitrogen to nitrate. Science (Washington DC), 235: 473-476, 1987.
15. Leibovich, S. J., Polverini, P. J., Fong, T. W., Harlow, L. A., and Koch, A. E. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. USA, 91: 4190-4194, 1994.
16. Talmadge, J. E., Key, M. E., and Hart, I. R. Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin. Cancer Res., 41: 1271-1280, 1981.
17. Hart, I. R. The selection and characterization of an invasive variant of the B16 melanoma. Am. J. Pathol., 97: 587-600, 1979.
18. Acerbis, G., Cleris, L., Rodolfo, M , Parmiani, G., and Formelli, F. Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosourea on spontaneous metastases of a non-immunogenic murine tumour. Cancer Immunol. Immunother., 34: 383-388, 1992.
19. van Elsas, A., Hurwitz, A. A., and Allison, J. P. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J. Exp Med., 190: 355-366, 1999.
20. Dong, Z., Qi, X., Xie, K., and Fidler, I. J. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide-nonresponsive murine macrophages. J. Immunol., 757: 2717-2724, 1993.
21. Xie, K., Huang, S.. Dong, Z., Juang, S. H., Gutman, M., Xie, Q. W., Nathan, C., and Fidler, I. J. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181: 1333-1343, 1995.
22. Yoon, S. S., Fidler, I. J., Beltran, P. J., Bucana, C. D., Wang, Y. F., and Fan, D. Intratumoral heterogeneity for and epigenetic modulation of mdr-1 expression in murine melanoma. Melanoma Res., 7: 275-287, 1997.
23. Xie, K., Wang, Y., Huang, S., Xu, L., Bielenberg, D., Salas, T., McConkey, D. J., Jiang, W., and Fidler, I. J. Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with downregulation of Bcl-2. Oncogene, 15: 771-779, 1997.
24. Cui, S., Reichner, J. S., Mateo, R. B., and Albina, J. E. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res., 54: 2462-2467, 1994.
25. Sveinbjornsson, B., Olsen, R., Seternes, O. M., and Seljelid, R. Macrophage cytotoxicity against murine Meth A sarcoma involves nitric oxide-mediated apoptosis. Biochem. Biophys. Res. Commun., 223: 643-649, 1996.
26. Li, L., Kilbourn, R. G., Adams, J., and Fidler, I J. Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res., 57: 2531-2535, 1991.
27. Fehsel, K., Kroncke, K-D., Meyer, K. L., Huber, H., Wahn, V., and Kolb-Bachofen, V. Nitric oxide induces apoptosis in murine thymocytes. J. Immunol., 755: 2858-2865, 1995.
28. Geng, Y. J., Hellstrand, K., Wennmalm, A., and Hansson, G. K. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to IFN-γ and TNF-α. Cancer Res., 56: 866-874, 1996.